Back

Cardiac myosin inhibitor MYK-581 prevents development of hypertrophic cardiomyopathy phenotype in human iPSC models

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular and immune mechanisms in cardiomyopathy Cardiomyopathies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Bjorn Knollmann

Vanderbilt University Medical Center, Nashville (United States of America)

4 More presentations in this session

Presentation thumbnail
Murine cytomegalovirus infection triggers onset of arrhythmogenic cardiomyopathy in Pkp2-deficient mice through a macrophage-driven immune response
Associate Professor B. Gerull (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Sex-specific effects of oestrogen in Takotsubo syndrome: protective in females, detrimental in males
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
AAV-mediated gene therapy improves cardiac function in humanized PLN-R14del mice: a preclinical model of PLN-R14del induced cardiomyopathy
Miss K. Gaar-Humphreys (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
The interleukin-6/glycoprotein 130 pathway in cardiomyocytes contributes to the pathogenesis of sepsis-induced cardiomyopathy
Doctor S. Graeger (Greifswald, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular and immune mechanisms in cardiomyopathy
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
thumbnail
Congress Presentation
State-of-the-art lecture on precision medicine in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Summary of the study selected for the John Shillingford Award

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources